Skip to main content

MCL Status Granted For Some Ethicon Hernia Mesh Lawsuits

MCL Status Granted For Some Ethicon Hernia Mesh Lawsuits

MCL Status Granted For Some Ethicon Hernia Mesh Lawsuits

Introduction

In a notice published on Wednesday, the New Jersey Supreme Court granted multicounty litigation (MCL) status to all the pending and future hernia mesh lawsuits against Johnson & Johnson and its subsidiary Ethicon Inc.

The announcement applies only to Physiomesh Flexible Composite Mesh; the Supreme Court declined to consolidate cases associated with similar devices. The multidistrict litigation (MDL No. 2782; In Re: Ethicon Physiomesh Flexible Composite Hernia Mesh Products Liability Litigation) holds more than 900 lawsuits claiming the mesh is defectively designed and is prone to break and migrate inside the body and cause severe damages.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!